Site-specific antioxidative therapy for prevention of atherosclerosis and cardiovascular disease

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Otani, Hajime ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; CALORIE RESTRICTION; CARDIOVASCULAR DISEASE; ENDURANCE EXERCISE; MOLECULAR AND CELLULAR BIOLOGIES; PATHOPHYSIOLOGY; REDOX SIGNALING; SITE-SPECIFIC;

CYTOLOGY; TISSUE;

DISEASES;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; XANTHINE OXIDASE; ANTIOXIDANT;

AGING; ATHEROSCLEROSIS; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; ENDURANCE TRAINING; ENZYME INHIBITION; EXERCISE; HUMAN; INTRAABDOMINAL FAT; LIFESPAN; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; UPREGULATION; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; HEART MUSCLE ISCHEMIA; METABOLISM; MITOCHONDRION;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; MYOCARDIAL ISCHEMIA; ORGAN SPECIFICITY;

EID: 84878337315     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/796891     Document Type: Review

References (142)

1. Sohal R. S., Orr W. C., The redox stress hypothesis of aging. Free Radical Biology and Medicine 2012 52 539 555 10.1016/j.freeradbiomed.2011.10.445
2. Liu Y., Fiskum G., Schubert D., Generation of reactive oxygen species by the mitochondrial electron transport chain. Journal of Neurochemistry 2002 80 5 780 787 2-s2.0-0036319021 10.1046/j.0022-3042.2002.00744.x (Pubitemid 34809230)
3. Choksi K. B., Nuss J. E., DeFord J. H., Papaconstantinou J., Mitochondrial electron transport chain functions in long-lived Ames dwarf mice. Aging 2011 3 8 754 767
4. Rueckschloss U., Duerrschmidt N., Morawietz H., NADPH oxidase in endothelial cells: impact on atherosclerosis. Antioxidants and Redox Signaling 2003 5 2 171 180 2-s2.0-0037394160 (Pubitemid 36457593)
5. Hajer G. R., van Haeften T. W., Visseren F. L. J., Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008 29 24 2959 2971 2-s2.0-58049219012 10.1093/eurheartj/ehn387
6. Otani H., Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxidants & Redox Signaling 2011 15 7 1911 1926 10.1089/ars.2010.3739
7. Murdoch C. E., Alom-Ruiz S. P., Wang M., Zhang M., Walker S., Yu B., Brewer A., Shah A. M., Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Research in Cardiology 2011 106 4 527 538 2-s2.0-79959704368 10.1007/s00395-011-0179-7
8. Yokoyama M., Inoue N., How vascular NAD(P)H oxidase activity and Nox isoform expression are regulated. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 9 1540 1541 2-s2.0-4444251169 10.1161/01.ATV.0000142356.48952.33 (Pubitemid 39180874)
9. Yang Y. M., Huang A., Kaley G., Sun D., eNOS uncoupling and endothelial dysfunction in aged vessels. American Journal of Physiology 2009 297 5 H1829 H1836 2-s2.0-70350459448 10.1152/ajpheart.00230.2009
10. Förstermann U., Münzel T., Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006 113 13 1708 1714 2-s2.0-33645780634 10.1161/CIRCULATIONAHA.105.602532
11. Oak J. H., Cai H., Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes 2007 56 1 118 126 2-s2.0-33847073821 10.2337/db06-0288
12. Nedeljkovic Z. S., Gokce N., Loscalzo J., Mechanisms of oxidative stress and vascular dysfunction. Postgraduate Medical Journal 2003 79 930 195 200 2-s2.0-0037514194 10.1136/pmj.79.930.195 (Pubitemid 36605780)
13. Guthikonda S., Sinkey C., Barenz T., Haynes W. G., Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 2003 107 3 416 421 2-s2.0-0037469205 10.1161/01.CIR.0000046448.26751.58 (Pubitemid 36158043)
14. Rapola J. M., Virtamo J., Ripatti S., Huttunen J. K., Albanes D., Taylor P. R., Heinonen O. P., Randomised trial of α -tocopherol and β -carotene supplements on incidence of major coronary events in men with previous myocardial infarction. The Lancet 1997 349 9067 1715 1720 2-s2.0-0030916162 10.1016/S0140-6736(97)01234-8 (Pubitemid 27252669)
15. Siems W., Sommerburg O., Schild L., Augustin W., Langhans C. D., Wiswedel I., Beta-carotene cleavage products induce oxidative stress in vitro by impairing mitochondrial respiration. The FASEB Journal 2002 16 10 1289 1291 2-s2.0-0036675753
16. Kidd P., Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Alternative Medicine Review 2011 16 4 355 364
17. Murry C. E., Jennings R. B., Reimer K. A., Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986 74 5 1124 1136 2-s2.0-0022970945 (Pubitemid 17174962)
18. Bolli R., The late phase of preconditioning. Circulation Research 2000 87 11 972 983 2-s2.0-0034711508
19. Otani H., Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities. Antioxidants and Redox Signaling 2008 10 2 207 247 2-s2.0-37549011356 10.1089/ars.2007.1679
20. Baines C. P., Goto M., Downey J. M., Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. Journal of Molecular and Cellular Cardiology 1997 29 1 207 216 2-s2.0-0030890196 10.1006/jmcc.1996.0265 (Pubitemid 27129144)
21. Chen W., Gabel S., Steenbergen C., Murphy E., A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circulation Research 1995 77 2 424 429 2-s2.0-0029160860
22. Tritto I., D'Andrea D., Eramo N., Scognamiglio A., de Simone C., Violante A., Esposito A., Chiariello M., Ambrosio G., Oxygen radicals can induce preconditioning in rabbit hearts. Circulation Research 1997 80 5 743 748 2-s2.0-0030888801 (Pubitemid 27181357)
23. Otani H., Reactive oxygen species as mediators of signal transduction in ischemic preconditioning. Antioxidants and Redox Signaling 2004 6 2 449 469 2-s2.0-1542619245 10.1089/152308604322899521 (Pubitemid 38332603)
24. Yamashita N., Hoshida S., Taniguchi N., Kuzuya T., Hori M., Whole-body hyperthermia provides biphasic cardioprotection against ischemia/reperfusion injury in the rat. Circulation 1998 98 14 1414 1421 2-s2.0-0032491193 (Pubitemid 28462802)
25. Bedard K., Krause K. H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007 87 1 245 313 2-s2.0-33846794822 10.1152/physrev.00044.2005 (Pubitemid 46209993)
26. Nauseef W. M., Biological roles for the NOX family NADPH oxidases. The Journal of Biological Chemistry 2008 283 25 16961 16965 2-s2.0-47749151450 10.1074/jbc.R700045200
27. Touyz R. M., Chen X., Tabet F., Yao G., He G., Quinn M. T., Pagano P. J., Schiffrin E. L., Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circulation Research 2002 90 11 1205 1213 2-s2.0-0037076798 10.1161/01.RES.0000020404.01971.2F (Pubitemid 34786906)
28. Hattori Y., Akimoto K., Gross S. S., Hattori S., Kasai K., Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia 2005 48 6 1066 1074 2-s2.0-21344462138 10.1007/s00125-005-1766-7 (Pubitemid 40909640)
29. Li J. M., Shah A. M., Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. role of the p47phox subunit. The Journal of Biological Chemistry 2003 278 14 12094 12100 2-s2.0-0037809230 10.1074/jbc.M209793200 (Pubitemid 36800187)
30. Ray R., Murdoch C. E., Wang M., Santos C. X., Zhang M., Alom-Ruiz S., Anilkumar N., Ouattara A., Cave A. C., Walker S. J., Grieve D. J., Charles R. L., Eaton P., Brewer A. C., Shah A. M., Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 6 1368 1376 2-s2.0-79957517872 10.1161/ATVBAHA.110.219238
31. Manrique C., Lastra G., Gardner M., Sowers J. R., The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Medical Clinics of North America 2009 93 3 569 582 2-s2.0-65449118734 10.1016/j.mcna.2009.02.014
32. Sata M., Fukuda D., Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. Journal of Medical Investigation 2010 57 1-2 12 25 2-s2.0-77749298626
33. Boyle J. J., Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Current Vascular Pharmacology 2005 3 1 63 68 2-s2.0-11844262719 10.2174/1570161052773861 (Pubitemid 40089528)
34. Wang G., Woo C. W. H., Sung F. L., Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 11 1777 1783 2-s2.0-0036847780 10.1161/01.ATV.0000035404.18281.37 (Pubitemid 35331053)
35. Zhang W., Elimban V., Nijjar M. S., Gupta S. K., Dhalla N. S., Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Experimental and Clinical Cardiology 2003 8 4 173 183 2-s2.0-3142770716 (Pubitemid 38923454)
36. Mehta P. K., Griendling K. K., Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. American Journal of Physiology 2007 292 1 C82 C97 2-s2.0-33846362954 10.1152/ajpcell. 00287.2006 (Pubitemid 46127306)
37. Zhao W., Zhao T., Chen Y., Ahokas R. A., Sun Y., Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Molecular and Cellular Biochemistry 2008 317 1-2 43 50 2-s2.0-53149102406 10.1007/s11010-008-9803-8
38. Berg A. H., Scherer P. E., Adipose tissue, inflammation, and cardiovascular disease. Circulation Research 2005 96 9 939 949 2-s2.0-19044393872 10.1161/01.RES.0000163635.62927.34 (Pubitemid 40712793)
39. El-Swefy S., Schaefer E. J., Seman L. J., van Dongen D., Sevanian A., Smith D. E., Ordovas J. M., El-Sweidy M., Meydani M., The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters. Atherosclerosis 2000 149 2 277 286 2-s2.0-0034099364 10.1016/S0021-9150(99)00331-7 (Pubitemid 30145537)
40. Rikitake Y., Liao J. K., Rho GTPases, statins, and nitric oxide. Circulation Research 2005 97 12 1232 1235 2-s2.0-33644694919 10.1161/01.RES.0000196564.18314.23
41. Hordijk P. L., Regulation of NADPH oxidases: the role of Rac proteins. Circulation Research 2006 98 4 453 462 2-s2.0-33645285957 10.1161/01.RES. 0000204727.46710.5e
42. Bendall J. K., Cave A. C., Heymes C., Gall N., Shah A. M., Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 2002 105 3 293 296 2-s2.0-0037154308 10.1161/hc0302.103712 (Pubitemid 34106175)
43. Kang B. Y., Mehta J. L., Rosuvastatin attenuates Ang II-mediated cardiomyocyte hypertrophy via inhibition of LOX-1. Journal of Cardiovascular Pharmacology and Therapeutics 2009 14 4 283 291 2-s2.0-70449652155 10.1177/1074248409344329
44. Zhou Q., Liao J. K., Rho kinase: an important mediator of atherosclerosis and vascular disease. Current Pharmaceutical Design 2009 15 27 3108 3115 2-s2.0-70449445715 10.2174/138161209789057986
45. Szostak J., Laurant P., The forgotten face of regular physical exercise: a 'natural' anti-atherogenic activity. Clinical Science 2011 121 3 91 106 2-s2.0-79955633419 10.1042/CS20100520
46. Pacher P., Nivorozhkin A., Szabó C., Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacological Reviews 2006 58 1 87 114 2-s2.0-33644631485 10.1124/pr.58.1.6
47. Campion E. W., Glynn R. J., DeLabry L. O., Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. The American Journal of Medicine 1987 82 3 421 426 2-s2.0-0023634573
48. Li J. M., Shah A. M., Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. American Journal of Physiology 2004 287 5 R1014 R1030 2-s2.0-6344285417 10.1152/ajpregu.00124.2004 (Pubitemid 39391043)
49. Harrison D., Griendling K. K., Landmesser U., Hornig B., Drexler H., Role of oxidative stress in atherosclerosis. American Journal of Cardiology 2003 91 3, supplement 7 11 2-s2.0-0037421492 10.1016/S0002-9149(02)03144-2 (Pubitemid 36351457)
50. Madamanchi N. R., Vendrov A., Runge M. S., Oxidative stress and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1 29 38 2-s2.0-11144225245 10.1161/01.ATV.0000150649.39934.13 (Pubitemid 40054251)
51. Bonomini F., Tengattini S., Fabiano A., Bianchi R., Rezzani R., Atherosclerosis and oxidative stress. Histology and Histopathology 2008 23 1-3 381 390 2-s2.0-38149090852
52. Landmesser U., Spiekermann S., Preuss C., Sorrentino S., Fischer D., Manes C., Mueller M., Drexler H., Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 943 948 2-s2.0-34247262775 10.1161/01.ATV.0000258415.32883.bf (Pubitemid 46606729)
53. McNally J. S., Davis M. E., Giddens D. P., Saha A., Hwang J., Dikalov S., Jo H., Harrison D. G., Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. American Journal of Physiology 2003 285 6 H2290 H2297 2-s2.0-0344185339 (Pubitemid 37443044)
54. Li P. F., Dietz R., von Harsdorf R., Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 1997 96 10 3602 3609 2-s2.0-0030774231 (Pubitemid 27513439)
55. Zhang C., Xu X., Potter B. J., Wang W., Kuo L., Michael L., Bagby G. J., Chilian W. M., TNF- α contributes to endothelial dysfunction in ischemia/reperfusion injury. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 3 475 480 2-s2.0-33646544087 10.1161/01.ATV.0000201932.32678.7e
56. Gao X., Zhang H., Belmadani S., Wu J., Xu X., Elford H., Potter B. J., Zhang C., Role of TNF- α -induced reactive oxygen species in endothelial dysfunction during reperfusion injury. American Journal of Physiology 2008 295 6 H2242 H2249 2-s2.0-57349197115 10.1152/ajpheart.00587.2008
57. Kleinbongard P., Schulz R., Heusch G., TNF α in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Failure Reviews 2011 16 1 49 69 2-s2.0-78650971588 10.1007/s10741-010-9180-8
58. Yamamoto Y., Ogino K., Igawa G., Matsuura T., Kaetsu Y., Sugihara S., Matsubara K., Miake J., Hamada T., Yoshida A., Igawa O., Yamamoto T., Shigemasa C., Hisatome I., Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats. Hypertension Research 2006 29 11 915 921 2-s2.0-33846098268 10.1291/hypres.29.915 (Pubitemid 46062122)
59. Kushiyama A., Okubo H., Sakoda H., Kikuchi T., Fujishiro M., Sato H., Xanthine oxidoreductase is involved in macrophage foam cell formation and atherosclerosis development. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 291 298 10.1161/ATVBAHA.111.234559
60. Dogan A., Yarlioglues M., Kaya M. G., Karadag Z., Dogan S., Ardic I., Dogdu O., Kilinc Y., Zencir C., Akpek M., Ozdogru I., Oguzhan A., Kalay N., Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients. Blood Pressure 2011 20 3 182 187 2-s2.0-79957524603 10.3109/08037051.2010.538977
61. Doehner W., Schoene N., Rauchhaus M., Leyva-Leon F., Pavitt D. V., Reaveley D. A., Schuler G., Coats A. J. S., Anker S. D., Hambrecht R., Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002 105 22 2619 2624 2-s2.0-0037024270 10.1161/01.CIR.0000017502.58595.ED (Pubitemid 34596038)
62. Manning A. S., Coltart D. J., Hearse D. J., Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circulation Research 1984 55 4 545 548 2-s2.0-0021690255 (Pubitemid 15201919)
63. Ignarro L. J., Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension 1990 16 5 477 483 2-s2.0-0025153863 (Pubitemid 20368334)
64. Moncada S., Palmer R. M. J., Higgs E. A., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991 43 2 109 142 2-s2.0-0025883342
65. Palmer R. M. J., Ferrige A. G., Moncada S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987 327 6122 524 526 2-s2.0-0023198721 (Pubitemid 17085822)
66. Mayer B., Hemmens B., Biosynthesis and action of nitric oxide in mammalian cells. Trends in Biochemical Sciences 1997 22 12 477 481 2-s2.0-0030694038 10.1016/S0968-0004(97)01147-X (Pubitemid 27515914)
67. Stuehr D., Pou S., Rosen G. M., Oxygen reduction by nitric-oxide synthases. The Journal of Biological Chemistry 2001 276 18 14533 14536 2-s2.0-0035805555 10.1074/jbc.R100011200
68. Abu-Soud H. M., Stuehr D. J., Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proceedings of the National Academy of Sciences of the United States of America 1993 90 22 10769 10772 2-s2.0-0027525273 10.1073/pnas.90.22.10769 (Pubitemid 23347124)
69. Moens A. L., Kass D. A., Tetrahydrobiopterin and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 2439 2444 10.1161/01.ATV.0000243924.00970.cb (Pubitemid 44607463)
70. Moens A. L., Kass D. A., Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease. Journal of Cardiovascular Pharmacology 2007 50 3 238 246 2-s2.0-34548748213 10.1097/FJC.0b013e318123f854 (Pubitemid 47428970)
71. Tarpey M. M., Sepiapterin treatment in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 10 1519 1521 2-s2.0-0036790531 10.1161/01.ATV.0000038144.37823.BF
72. Vásquez-Vivar J., Duquaine D., Whitsett J., Kalyanaraman B., Rajagopalan S., Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 10 1655 1661 2-s2.0-0036790604 10.1161/01.ATV.0000029122.79665.D9
73. Vasquez-Vivar J., Martasek P., Whitsett J., Joseph J., Kalyanaraman B., The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochemical Journal 2002 362 3 733 739 2-s2.0-0037086565 10.1042/0264-6021:3620733 (Pubitemid 34242326)
74. Thöny B., Auerbach G., Blau N., Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochemical Journal 2000 347, part 1 1 16 2-s2.0-0034176921 10.1042/0264-6021:3470001 (Pubitemid 30199034)
75. Fiege B., Ballhausen D., Kierat L., Leimbacher W., Goriounov D., Schircks B., Thöny B., Blau N., Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration. Molecular Genetics and Metabolism 2004 81 1 45 51 2-s2.0-0347086140 10.1016/j.ymgme.2003.09.014 (Pubitemid 38064431)
76. Shi W., Meininger C. J., Haynes T. E., Hatakeyama K., Wu G., Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochemistry and Biophysics 2004 41 3 415 433 2-s2.0-23244467263 10.1385/CBB:41:3:415 (Pubitemid 41270753)
77. Wang X., Hattori Y., Satoh H., Iwata C., Banba N., Monden T., Uchida K., Kamikawa Y., Kasai K., Tetrahydrobiopterin prevents endothelial dysfunction and restores adiponectin levels in rats. European Journal of Pharmacology 2007 555 1 48 53 2-s2.0-33845774335 10.1016/j.ejphar.2006.10.017 (Pubitemid 46013851)
78. Shinozaki K., Nishio Y., Yoshida Y., Koya D., Ayajiki K., Masada M., Kashiwagi A., Okamura T., Supplement of tetrahydrobiopterin by a gene transfer of GTP cyclohydrolase I cDNA improves vascular dysfunction in insulin-resistant rats. Journal of Cardiovascular Pharmacology 2005 46 4 505 512 2-s2.0-26044436512 10.1097/01.fjc.0000177981.91434.ba (Pubitemid 41407581)
79. Katusic Z. S., d'Uscio L. V., Nath K. A., Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends in Pharmacological Sciences 2009 30 1 48 54 2-s2.0-58149138838 10.1016/j.tips.2008. 10.003
80. Heitzer T., Brockhoff C., Mayer B., Warnholtz A., Mollnau H., Henne S., Meinertz T., Münzel T., Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circulation Research 2000 86 2 E36 E41 2-s2.0-0034602878
81. Sayed N., Kim D. D., Fioramonti X., Iwahashi T., Durán W. N., Beuve A., Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circulation Research 2008 103 6 606 614 2-s2.0-53249088371 10.1161/CIRCRESAHA.108.175133
82. Gonzalez D. R., Beigi F., Treuer A. V., Hare J. M., Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proceedings of the National Academy of Sciences of the United States of America 2007 104 51 20612 20617 2-s2.0-38049134302 10.1073/pnas.0706796104
83. Lim G., Venetucci L., Eisner D. A., Casadei B., Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling. Cardiovascular Research 2008 77 2 256 264 2-s2.0-38849108758 10.1093/cvr/cvm012 (Pubitemid 351197636)
84. Shimazu T., Otani H., Yoshioka K., Fujita M., Okazaki T., Iwasaka T., Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction. American Journal of Physiology 2011 301 5 H2061 H2072 10.1152/ajpheart.00525.2011
85. Okazaki T., Otani H., Shimazu T., Yoshioka K., Fujita M., Katano T., Ito S., Iwasaka T., Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. Journal of Molecular and Cellular Cardiology 2011 50 3 534 544 2-s2.0-79551582218 10.1016/j.yjmcc.2010.12.010
86. Sun J., Morgan M., Shen R. F., Steenbergen C., Murphy E., Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circulation Research 2007 101 11 1155 1163 2-s2.0-36348964192 10.1161/CIRCRESAHA.107.155879 (Pubitemid 350146442)
87. Kirkinezos I. G., Moraes C. T., Reactive oxygen species and mitochondrial diseases. Seminars in Cell and Developmental Biology 2001 12 6 449 457 2-s2.0-0035782650 10.1006/scdb.2001.0282
88. Verdejo H. E., del Campo A., Troncoso R., Gutierrez T., Toro B., Quiroga C., Mitochondria, myocardial remodeling, and cardiovascular disease. Current Hypertension Reports 2012 14 6 532 539 10.1007/s11906-012-0305-4
89. Chance B., Sies H., Boveris A., Hydroperoxide metabolism in mammalian organs. Physiological Reviews 1979 59 3 527 605 2-s2.0-0018776894 (Pubitemid 9236599)
90. 2 formation by rat heart mitochondria on substrate availability and donor age. Journal of Bioenergetics and Biomembranes 1997 29 1 89 95 2-s2.0-0030615104 10.1023/A:1022420007908 (Pubitemid 27114081)
91. Wallace D. C., A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annual Review of Genetics 2005 39 359 407 2-s2.0-23844558266 10.1146/annurev.genet.39.110304. 095751 (Pubitemid 43011120)
92. Gomes E. C., Silva A. N., de Oliveira M. R., Oxidants, antioxidants, and the beneficial roles of exercise-induced production of reactive species. Oxidative Medicine and Cellular Longevity 2012 2012 12 756132 10.1155/2012/756132
93. Herlein J. A., Fink B. D., Henry D. M., Yorek M. A., Teesch L. M., Sivitz W. I., Mitochondrial superoxide and coenzyme Q in insulin-deficient rats: increased electron leak. American Journal of Physiology 2011 301 6 R1616 R1624 10.1152/ajpregu.00395.2011
94. Jastroch M., Divakaruni A. S., Mookerjee S., Treberg J. R., Brand M. D., Mitochondrial proton and electron leaks. Essays in Biochemistry 2010 47 53 67 2-s2.0-79551610255
95. Reznick R. M., Shulman G. I., The role of AMP-activated protein kinase in mitochondrial biogenesis. The Journal of Physiology 2006 574, part 1 33 39 2-s2.0-33745215883 10.1113/jphysiol.2006.109512 (Pubitemid 43905794)
96. Viollet B., Guigas B., Leclerc J., Hébrard S., Lantier L., Mounier R., Andreelli F., Foretz M., AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiologica 2009 196 1 81 98 2-s2.0-63849206613 10.1111/j.1748-1716.2009.01970. x
97. Yassine H. N., Marchetti C. M., Krishnan R. K., Vrobel T. R., Gonzalez F., Kirwan J. P., Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults-a randomized clinical trial. Journals of Gerontology A 2009 64 1 90 95 2-s2.0-64249092904 10.1093/gerona/gln032
98. Cantó C., Auwerx J., PGC-1 α SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Current Opinion in Lipidology 2009 20 2 98 105 2-s2.0-64549127790 10.1097/MOL.0b013e328328d0a4
99. Valle I., Álvarez-Barrientos A., Arza E., Lamas S., Monsalve M., PGC-1 α regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovascular Research 2005 66 3 562 573 2-s2.0-19444365211 10.1016/j.cardiores.2005.01.026 (Pubitemid 40725768)
100. Irrcher I., Ljubicic V., Hood D. A., Interactions between ROS and AMP kinase activity in the regulation of PGC-1 α transcription in skeletal muscle cells. American Journal of Physiology 2009 296 1 C116 C123 2-s2.0-58349118928 10.1152/ajpcell.00267.2007
101. Lira V. A., Brown D. L., Lira A. K., Kavazis A. N., Soltow Q. A., Zeanah E. H., Criswell D. S., Nitric oxide and AMPK cooperatively regulate PGC-1 α in skeletal muscle cells. The Journal of Physiology 2010 588 18 3551 3566 2-s2.0-77956722579 10.1113/jphysiol.2010.194035
102. Nisoli E., Clementi E., Paolucci C., Cozzi V., Tonello C., Sciorati C., Bracale R., Valerio A., Francolini M., Moncada S., Carruba M. O., Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003 299 5608 896 899 2-s2.0-0347579845 10.1126/science.1079368 (Pubitemid 36182449)
103. Piantadosi C. A., Suliman H. B., Mitochondrial transcription factor A induction by redox activation of nuclear respiratory factor 1. The Journal of Biological Chemistry 2006 281 1 324 333 2-s2.0-33644852502 10.1074/jbc. M508805200 (Pubitemid 43671192)
104. Kukidome D., Nishikawa T., Sonoda K., Imoto K., Fujisawa K., Yano M., Motoshima H., Taguchi T., Matsumura T., Araki E., Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 2006 55 1 120 127 2-s2.0-33644749330 10.2337/diabetes.55.1.120 (Pubitemid 43343306)
105. Scarpulla R. C., Vega R. B., Kelly D. P., Transcriptional integration of mitochondrial biogenesis. Trends in Endocrinology & Metabolism 2012 23 9 459 466 10.1016/j.tem.2012.06.006
106. Scarpulla R. C., Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiological Reviews 2008 88 2 611 638 2-s2.0-42049114034 10.1152/physrev.00025.2007 (Pubitemid 351520089)
107. Constant J., Alcohol, ischemic heart disease, and the French paradox. Coronary Artery Disease 1997 8 10 645 649 2-s2.0-0031471548 (Pubitemid 28029590)
108. Dasgupta B., Milbrandt J., Resveratrol stimulates AMP kinase activity in neurons. Proceedings of the National Academy of Sciences of the United States of America 2007 104 17 7217 7222 2-s2.0-34249846128 10.1073/pnas.0610068104 (Pubitemid 47186035)
109. Howitz K. T., Bitterman K. J., Cohen H. Y., Lamming D. W., Lavu S., Wood J. G., Zipkin R. E., Chung P., Kisielewski A., Zhang L. L., Scherer B., Sinclair D. A., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003 425 6954 191 196 2-s2.0-0141719702 10.1038/nature01960 (Pubitemid 37150899)
110. Swindell W. R., Comparative analysis of microarray data identifies common responses to caloric restriction among mouse tissues. Mechanisms of Ageing and Development 2008 129 3 138 153 2-s2.0-39149086075 10.1016/j.mad.2007.11.003
111. Wood J. G., Rogina B., Lavu S., Ilowitz K., Helfand S. L., Tatar M., Sinclair D., Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004 430 7000 686 689 (Pubitemid 39061685)
112. Biala A., Tauriainen E., Siltanen A., Shi J., Merasto S., Louhelainen M., Martonen E., Finckenberg P., Muller D. N., Mervaala E., Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes. Blood Pressure 2010 19 3 196 205 2-s2.0-77952837883 10.3109/08037051.2010.481808
113. Csiszar A., Labinskyy N., Pinto J. T., Ballabh P., Zhang H., Losonczy G., Pearson K., de Cabo R., Pacher P., Zhang C., Ungvari Z., Resveratrol induces mitochondrial biogenesis in endothelial cells. American Journal of Physiology 2009 297 1 H13 H20 2-s2.0-67650091375 10.1152/ajpheart.00368.2009
114. Ungvari Z., Sonntag W. E., de Cabo R., Baur J. A., Csiszar A., Mitochondrial protection by resveratrol. Exercise and Sport Sciences Reviews 2011 39 3 128 132 2-s2.0-79960006725 10.1097/JES.0b013e3182141f80
115. Matthias A., Ohlson K. B. E., Fredriksson J. M., Jacobsson A., Nedergaard J., Cannon B., Thermogenic responses in brown fat cells are fully UCP1-dependent. UCP2 or UCP3 do not substitute for UCP1 in adrenergically or fatty acid-induced thermogenesis. The Journal of Biological Chemistry 2000 275 33 25073 25081 2-s2.0-0034682795 10.1074/jbc.M000547200
116. Nègre-Salvayre A., Hirtz C., Carrera G., Cazenave R., Troly M., Salvayre R., Pénicaud L., Casteilla L., A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. The FASEB Journal 1997 11 10 809 815 2-s2.0-0038061012 (Pubitemid 27349566)
117. Rousset S., Alves-Guerra M. C., Mozo J., Miroux B., Cassard-Doulcier A. M., Bouillaud F., Ricquier D., The biology of mitochondrial uncoupling proteins. Diabetes 2004 53 supplement 1 S130 S135 2-s2.0-0842306477 (Pubitemid 38168705)
118. Korshunov S. S., Skulachev V. P., Starkov A. A., High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Letters 1997 416 1 15 18 2-s2.0-0030729851 10.1016/S0014-5793(97)01159-9 (Pubitemid 27470791)
119. Chandel N., Budinger G. R. S., Kemp R. A., Schumacker P. T., Inhibition of cytochrome-c oxidase activity during prolonged hypoxia. American Journal of Physiology 1995 268 6 L918 L925 2-s2.0-0029060562
120. Echtay K. S., Roussel D., St-Plerre J., Jekabsons M. B., Cadenas S., Stuart J. A., Harper J. A., Roebuck S. J., Morrison A., Pickering S., Clapham J. C., Brand M. D., Superoxide activates mitochondrial uncoupling proteins. Nature 2002 415 6867 96 99 2-s2.0-18244379331 10.1038/415096a (Pubitemid 34062457)
121. Parker N., Vidal-Puig A., Brand M. D., Stimulation of mitochondrial proton conductance by hydroxynonenal requires a high membrane potential. Bioscience Reports 2008 28 2 83 88 2-s2.0-48249083981 10.1042/BSR20080002
122. Mailloux R. J., Harper M. E., Uncoupling proteins and the control of mitochondrial reactive oxygen species production. Free Radical Biology and Medicine 2011 51 6 1106 1115 10.1016/j.freeradbiomed.2011.06.022
123. Boss O., Samec S., Kühne F., Bijlenga P., Assimacopoulos-Jeannet F., Seydoux J., Giacobino J. P., Muzzin P., Uncoupling protein-3 expression in rodent skeletal muscle is modulated by food intake but not by changes in environmental temperature. The Journal of Biological Chemistry 1998 273 1 5 8 2-s2.0-0031972878 10.1074/jbc.273.1.5 (Pubitemid 28042165)
124. Millet L., Vidal H., Andreelli F., Larrouy D., Riou J. P., Ricquier D., Laville M., Langin D., Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. The Journal of Clinical Investigation 1997 100 11 2665 2670 2-s2.0-0031437096 (Pubitemid 28007533)
125. Tsuboyama-Kasaoka N., Tsunoda N., Maruyama K., Takahashi M., Kim H., Ikemoto S., Ezaki O., Up-regulation of uncoupling protein 3 (UCP3) mRNA by exercise training and down-regulation of UCP3 by denervation in skeletal muscles. Biochemical and Biophysical Research Communications 1998 247 2 498 503 2-s2.0-0032543351 10.1006/bbrc.1998.8818 (Pubitemid 28420855)
126. Schrauwen P., Hesselink M. K. C., Vaartjes I., Kornips E., Saris W. H. M., Giacobino J. P., Russell A., Effect of acute exercise on uncoupling protein 3 is a fat metabolism-mediated effect. American Journal of Physiology 2002 282 1 E11 E17 2-s2.0-0036072873 (Pubitemid 34654100)
127. Matsuda J., Hosoda K., Itoh H., Son C., Doi K., Tanaka T., Fukunaga Y., Inoue G., Nishimura H., Yoshimasa Y., Yamori Y., Nakao K., Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet. FEBS Letters 1997 418 1-2 200 204 2-s2.0-0030733473 10.1016/S0014-5793(97)01381-1 (Pubitemid 27514446)
128. Schrauwen P., Hoppeler H., Billeter R., Bakker A. H. F., Pendergast D. R., Fiber type dependent upregulation of human skeletal muscle UCP2 and UCP3 mRNA expression by high-fat diet. International Journal of Obesity 2001 25 4 449 456 2-s2.0-0035074179 10.1038/sj.ijo.0801566 (Pubitemid 32289635)
129. Kelly L. J., Vicario P. P., Thompson G. M., Candelore M. R., Doebber T. W., Ventre J., Wu M. S., Meurer R., Forrest M. J., Conner M. W., Cascieri M. A., Moller D. E., Peroxisome proliferator-activated receptors γ and α mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology 1998 139 12 4920 4927 2-s2.0-7844237506 (Pubitemid 28533438)
130. Patterson A. D., Shah Y. M., Matsubara T., Krausz K. W., Gonzalez F. J., Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity. Hepatology 2012 56 1 281 290 10.1002/hep.25645
131. Young M. E., Patil S., Ying J., Depre C., Ahuja H. S., Shipley G. L., Stepkowski S. M., Davies P. J. A., Taegtmeyer H., Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor α in the adult rodent heart. The FASEB Journal 2001 15 3 833 845 2-s2.0-0035085845 10.1096/fj.00-0351com (Pubitemid 32246002)
132. Murray A. J., Panagia M., Hauton D., Gibbons G. F., Clarke K., Plasma free fatty acids and peroxisome proliferator-activated receptor α in the control of myocardial uncoupling protein levels. Diabetes 2005 54 12 3496 3502 2-s2.0-33644666564 10.2337/diabetes.54.12.3496 (Pubitemid 43334341)
133. Chuang Y. C., Lin T. K., Huang H. Y., Peroxisome proliferator-activated receptors gamma/mitochondrial uncoupling protein 2 signaling protects against seizure-induced neuronal cell death in the hippocampus following experimental status epilepticus. Journal of Neuroinflammation 2012 9, article no 184 10.1186/1742-2094-9-184
134. Tao L., Liu H. R., Gao E., Teng Z. P., Lopez B. L., Christopher T. A., Ma X. L., Batinic-Haberle I., Willette R. N., Ohlstein E. H., Yue T. L., Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor- γ agonist in hypercholesterolemia. Circulation 2003 108 22 2805 2811 2-s2.0-10744223422 10.1161/01.CIR.0000097003. 49585.5E (Pubitemid 37498984)
135. Nissen S. E., Wolski K., Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. The New England Journal of Medicine 2007 356 24 2457 2471 2-s2.0-34250212715 (Pubitemid 46919772)
136. Psaty B. M., Furberg C. D., Rosiglitazone and cardiovascular risk. The New England Journal of Medicine 2007 356 24 2522 2524 2-s2.0-34250178250 (Pubitemid 46919780)
137. Masternak M. M., Bartke A., PPARs in calorie restricted and genetically long-lived mice. PPAR Research 2007 2007 7 2-s2.0-34548864933 10.1155/2007/28436 28436
138. Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., Fruchart J. C., Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998 98 19 2088 2093 2-s2.0-0032506273 (Pubitemid 28512236)
139. Perelas A., Tsoulkani A., Perrea D., Effects of lipid-lowering drugs on adiponectin. Current Vascular Pharmacology 2010 8 6 836 848 2-s2.0-78649358943
140. Barter P. J., Rye K. A., Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 1 39 46 2-s2.0-37549041988 10.1161/ATVBAHA.107.148817
141. Tuck M. L., Angiotensin-receptor blocking agents and the peroxisome proliferator-activated receptor- γ system. Current Hypertension Reports 2005 7 4 240 243 2-s2.0-24944463413 (Pubitemid 41309538)
142. Towfighi A., Ovbiagele B., Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention. Cerebrovascular Diseases 2008 26 2 106 112 2-s2.0-50049099439 10.1159/000139656